Pepcid and Platelet disorder - a phase IV clinical study of FDA data

Summary:

Platelet disorder is reported as a side effect among people who take Pepcid (famotidine), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Plavix, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Platelet disorder when taking Pepcid. It is created by eHealthMe based on reports of 54,527 people who have side effects when taking Pepcid from the FDA, and is updated regularly.

What is Pepcid?

Pepcid has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 55,772 Pepcid users. Check the latest studies of Pepcid.

What is Platelet disorder?

Platelet disorder is found to be associated with 329 drugs and 429 conditions by eHealthMe. Check the latest studies of Platelet disorder.

On Apr, 12, 2026

54,527 people reported to have side effects when taking Pepcid.
Among them, 30 people (0.06%) have Platelet disorder.

Among these 30 people:

How long have people been on Pepcid when they have Platelet disorder? *

What is the gender of people who have Platelet disorder when taking Pepcid? *

female: 62.5 %
male: 37.5 %

What is the age of people who have Platelet disorder when taking Pepcid? *

What are other drugs people take besides Pepcid? *

What are other side effects people have besides Platelet disorder? *

Dyspnea (difficult or laboured breathing): 9 people, 30.00%
Nausea (feeling of having an urge to vomit): 9 people, 30.00%
Oedema Peripheral (superficial swelling): 8 people, 26.67%
Thrombocytopenia (decrease of platelets in blood): 8 people, 26.67%
Fatigue (feeling of tiredness): 8 people, 26.67%
Heparin-Induced Thrombocytopenia: 7 people, 23.33%
Hypotension (abnormally low blood pressure): 7 people, 23.33%
Dizziness: 7 people, 23.33%
Anaemia (lack of blood): 7 people, 23.33%
Haematoma (collection of blood outside the blood vessels): 6 people, 20.00%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 4 people, 13.33%
Primary Myelofibrosis (primary disorder of the bone marrow): 3 people, 10.00%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 3 people, 10.00%
Retroperitoneal Cancer (cancer between the peritoneum and the posterior abdominal wall): 2 people, 6.67%
Psoriasis (immune-mediated disease that affects the skin): 2 people, 6.67%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 6.67%
Pain: 2 people, 6.67%
Nausea (feeling of having an urge to vomit): 2 people, 6.67%
Malignant Peritoneal Neoplasm (cancer tumour of peritoneum): 2 people, 6.67%
Viral Infection: 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Pepcid and have Platelet disorder?

- Check whether Platelet disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pepcid:

Pepcid (55,772 reports)

Browse all side effects of Pepcid:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Platelet disorder:

Platelet disorder (329 drugs)

Browse all the conditions that are associated with Platelet disorder:

Platelet disorder (429 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on famotidine (the active ingredients of Pepcid) and Pepcid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.